Liping Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liping Gu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Yongde Peng
Department of Endocrinology and Metabolism, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
3 shared publications- Yufan Wang
Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
3 shared publications Yuhang Ma
Department of Endocrinology and Metabolism, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
3 shared publicationsJiaying Yang
Department of Endocrinology and Metabolism, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publicationsMei Kang
Clinical Research Center, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publicationsShuai Yan
Department of Endocrinology and Metabolism, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publications
Latest Publications
- Open Access
- 5 September 2023
- Published by Wiley in Journal of Diabetes
- Vol. 16 (1)
The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China
Objective: This study investigated the association of economic status with metabolic index control in type 2 diabetes mellitus (T2DM) patients.Methods: In total, 37 454 T2DM patients from 10 National Metabolic Management Centers in China were recruited and categorized into two groups: a high‐gross domestic product (GDP) group (n = 23 993) and a low‐GDP group (n = 13 461). Sociodemographic characteristics, medical histories, and lifestyle factors were recorded. Logistic regression and interaction analysis were performed to evaluate the association of economic status and healthy lifestyle with metabolic control.Results: Compared to the low‐GDP group, there were fewer patients with glycated hemoglobin (HbA1c) levels ≥7% in the high‐GDP group. Fewer patients with a high GDP had an abnormal metabolic state (HbA1c ≥ 7%, blood pressure [BP] ≥130/80 mm Hg, total cholesterol [TCH] ≥4.5 mmol/L or body mass index [BMI] ≥24 kg/m2). The risks of developing HbA1c ≥ 7% (odds ratios [OR] = 0.545 [95% CI: 0.515–0.577], p < .001), BP ≥ 130/80 mm Hg (OR = 0.808 [95% CI: 0.770–0.849], p < .001), BMI ≥ 24 kg/m2 (OR = 0.840 [95% CI: 0.799–0.884], p < .001), and an abnormal metabolic state (OR = 0.533 [95% CI: 0.444–0.636], p < .001) were significantly lower in the high‐GDP group even after adjustment for confounding factors. Younger participants; those with a family history of diabetes, normal weight, and a physical activity level up to standard; and those who did not drink alcohol in the high‐GDP group were predisposed to better glycemic levels.Conclusions: T2DM patients in economically developed regions had better metabolic control, especially glycemic control. A healthy lifestyle had an additive effect on achieving glycemic goals, even among high‐GDP patients.
- 5 September 2023
- Published by Wiley in Journal of Diabetes
- Vol. 16 (1)
Open AccessThe effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China
Objective: This study investigated the association of economic status with metabolic index control in type 2 diabetes mellitus (T2DM) patients.Methods: In total, 37 454 T2DM patients from 10 National Metabolic Management Centers in China were recruited and categorized into two groups: a high‐gross domestic product (GDP) group (n = 23 993) and a low‐GDP group (n = 13 461). Sociodemographic characteristics, medical histories, and lifestyle factors were recorded. Logistic regression and interaction analysis were performed to evaluate the association of economic status and healthy lifestyle with metabolic control.Results: Compared to the low‐GDP group, there were fewer patients with glycated hemoglobin (HbA1c) levels ≥7% in the high‐GDP group. Fewer patients with a high GDP had an abnormal metabolic state (HbA1c ≥ 7%, blood pressure [BP] ≥130/80 mm Hg, total cholesterol [TCH] ≥4.5 mmol/L or body mass index [BMI] ≥24 kg/m2). The risks of developing HbA1c ≥ 7% (odds ratios [OR] = 0.545 [95% CI: 0.515–0.577], p < .001), BP ≥ 130/80 mm Hg (OR = 0.808 [95% CI: 0.770–0.849], p < .001), BMI ≥ 24 kg/m2 (OR = 0.840 [95% CI: 0.799–0.884], p < .001), and an abnormal metabolic state (OR = 0.533 [95% CI: 0.444–0.636], p < .001) were significantly lower in the high‐GDP group even after adjustment for confounding factors. Younger participants; those with a family history of diabetes, normal weight, and a physical activity level up to standard; and those who did not drink alcohol in the high‐GDP group were predisposed to better glycemic levels.Conclusions: T2DM patients in economically developed regions had better metabolic control, especially glycemic control. A healthy lifestyle had an additive effect on achieving glycemic goals, even among high‐GDP patients.
- Open Access
- 29 March 2022
- Published by World Scientific Pub Co Pte Ltd in Journal of Mechanics in Medicine and Biology
- Vol. 22 (03)
MULTI-FEATURE FUSION EMOTION RECOGNITION BASED ON RESTING EEG
- 29 March 2022
- Published by World Scientific Pub Co Pte Ltd in Journal of Mechanics in Medicine and Biology
- Vol. 22 (03)
Open AccessMULTI-FEATURE FUSION EMOTION RECOGNITION BASED ON RESTING EEG
- Open Access
- 9 December 2021
- Published by Wiley in Journal of Diabetes
- Vol. 14 (2) , 111-120
A stratified analysis of a deep learning algorithm in the diagnosis of diabetic retinopathy in a real‐world study
Background: The aim of our research was to prospectively explore the clinical value of a deep learning algorithm (DLA) to detect referable diabetic retinopathy (DR) in different subgroups stratified by types of diabetes, blood pressure, sex, BMI, age, glycosylated hemoglobin (HbA1c), diabetes duration, urine albumin‐to‐creatinine ratio (UACR), and estimated glomerular filtration rate (eGFR) at a real‐world diabetes center in China.Methods: A total of 1147 diabetic patients from Shanghai General Hospital were recruited from October 2018 to August 2019. Retinal fundus images were graded by the DLA, and the detection of referable DR (moderate nonproliferative DR or worse) was compared with a reference standard generated by one certified retinal specialist with more than 12 years of experience. The performance of DLA across different subgroups stratified by types of diabetes, blood pressure, sex, BMI, age, HbA1c, diabetes duration, UACR, and eGFR was evaluated.Results: For all 1674 gradable images, the area under the receiver operating curve, sensitivity, and specificity of the DLA for referable DR were 0.942 (95% CI, 0.920‐0.964), 85.1% (95% CI, 83.4%‐86.8%), and 95.6% (95% CI, 94.6%‐96.6%), respectively. The DLA showed consistent performance across most subgroups, while it showed superior performance in the subgroups of patients with type 1 diabetes, UACR ≥ 30 mg/g, and eGFR < 90 mL/min/1.73m2.Conclusions: This study showed that the DLA was a reliable alternative method for the detection of referable DR and performed superior in patients with type 1 diabetes and diabetic nephropathy who were prone to DR.
- 9 December 2021
- Published by Wiley in Journal of Diabetes
- Vol. 14 (2) , 111-120
Open AccessA stratified analysis of a deep learning algorithm in the diagnosis of diabetic retinopathy in a real‐world study
Background: The aim of our research was to prospectively explore the clinical value of a deep learning algorithm (DLA) to detect referable diabetic retinopathy (DR) in different subgroups stratified by types of diabetes, blood pressure, sex, BMI, age, glycosylated hemoglobin (HbA1c), diabetes duration, urine albumin‐to‐creatinine ratio (UACR), and estimated glomerular filtration rate (eGFR) at a real‐world diabetes center in China.Methods: A total of 1147 diabetic patients from Shanghai General Hospital were recruited from October 2018 to August 2019. Retinal fundus images were graded by the DLA, and the detection of referable DR (moderate nonproliferative DR or worse) was compared with a reference standard generated by one certified retinal specialist with more than 12 years of experience. The performance of DLA across different subgroups stratified by types of diabetes, blood pressure, sex, BMI, age, HbA1c, diabetes duration, UACR, and eGFR was evaluated.Results: For all 1674 gradable images, the area under the receiver operating curve, sensitivity, and specificity of the DLA for referable DR were 0.942 (95% CI, 0.920‐0.964), 85.1% (95% CI, 83.4%‐86.8%), and 95.6% (95% CI, 94.6%‐96.6%), respectively. The DLA showed consistent performance across most subgroups, while it showed superior performance in the subgroups of patients with type 1 diabetes, UACR ≥ 30 mg/g, and eGFR < 90 mL/min/1.73m2.Conclusions: This study showed that the DLA was a reliable alternative method for the detection of referable DR and performed superior in patients with type 1 diabetes and diabetic nephropathy who were prone to DR.
- 27 September 2020
- Published by Wiley in Journal of Diabetes
- Vol. 13 (4) , 318-329
Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes
Objective: This study aimed to explore the relationship of thyroid function and glucose metabolism and to investigate the changes in thyroid function after National Metabolic Management Center (MMC) management in type 2 diabetic mellitus (T2DM).Methods: A total of 2000 euthyroid participants from MMC in Shanghai General Hospital and a community physical examination were recruited. They were categorized into four groups: normal glucose tolerance (NGT, n = 132), prediabetes (N = 147), DM well‐controlled (T2DM with glycosylated hemoglobin [HbA1c] ≤ 7%, n = 505), and DM uncontrolled (T2DM with HbA1c > 7%, n = 1216). The parameters were compared among the groups and their changes before and after MMC follow‐up in DM uncontrolled group were observed.Results: Free triiodothyronine (FT3) and free thyroxine (FT4) levels varied significantly among groups. FT3 and FT4 levels negatively correlated with HbA1c level (P < 0.05), and positively correlated with the estimated glucose disposal rate (eGDR) (P < 0.05). Following MMC management, blood glucose and insulin resistance in the DM uncontrolled group were dramatically improved (P < 0.001). Meanwhile, FT3 was elevated compared to the baseline (from 4.51 ± 0.78 pmol/L to 4.68 ± 0.87 pmol/L, P < 0.05), and reverse triiodothyronine (r‐T3) decreased from 1.03 ± 0.24 nmol/L to 0.92 ± 0.25 nmol/L (P < 0.001). Thyroid‐stimulating hormone significantly decreased as well (P < 0.001).Conclusions: Decreased free thyroid hormone levels in normal range were associated with high glucose and insulin resistance. After MMC management, improvement of blood glucose and insulin resistance were accompanied by the restoration of low‐normal thyroid function.
- 27 September 2020
- Published by Wiley in Journal of Diabetes
- Vol. 13 (4) , 318-329
Lower free thyroid hormone levels are associated with high blood glucose and insulin resistance; these normalize with metabolic improvement of type 2 diabetes
Objective: This study aimed to explore the relationship of thyroid function and glucose metabolism and to investigate the changes in thyroid function after National Metabolic Management Center (MMC) management in type 2 diabetic mellitus (T2DM).Methods: A total of 2000 euthyroid participants from MMC in Shanghai General Hospital and a community physical examination were recruited. They were categorized into four groups: normal glucose tolerance (NGT, n = 132), prediabetes (N = 147), DM well‐controlled (T2DM with glycosylated hemoglobin [HbA1c] ≤ 7%, n = 505), and DM uncontrolled (T2DM with HbA1c > 7%, n = 1216). The parameters were compared among the groups and their changes before and after MMC follow‐up in DM uncontrolled group were observed.Results: Free triiodothyronine (FT3) and free thyroxine (FT4) levels varied significantly among groups. FT3 and FT4 levels negatively correlated with HbA1c level (P < 0.05), and positively correlated with the estimated glucose disposal rate (eGDR) (P < 0.05). Following MMC management, blood glucose and insulin resistance in the DM uncontrolled group were dramatically improved (P < 0.001). Meanwhile, FT3 was elevated compared to the baseline (from 4.51 ± 0.78 pmol/L to 4.68 ± 0.87 pmol/L, P < 0.05), and reverse triiodothyronine (r‐T3) decreased from 1.03 ± 0.24 nmol/L to 0.92 ± 0.25 nmol/L (P < 0.001). Thyroid‐stimulating hormone significantly decreased as well (P < 0.001).Conclusions: Decreased free thyroid hormone levels in normal range were associated with high glucose and insulin resistance. After MMC management, improvement of blood glucose and insulin resistance were accompanied by the restoration of low‐normal thyroid function.